Dry eye treatment company TearScience, which is considering plans for an initial public stock offering, now has a new chief financial officer. The medical device company has promoted Nicole Wicker from vice president of finance to CFO. Wicker joined TearScience in 2008 and guided the Morrisville, North Carolina company through its $44.5 million series C […]
TearScience, the dry eye treatment company fresh off a 510(k) clearance, is starting to explore its options for an initial public offering. But if TearScience does go public, there’s a chance it won’t be on the New York Stock Exchange or NASDAQ. Think SSE, SZSE or HKEX. CEO Tim Willis told a crowd at the […]
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
The dry eye treatment developed by TearScience received 510(k) clearance last week, about seven months after the company’s novel medical device received its first marketing go-ahead from the U.S. Food and Drug Administration. While the speed at which regulators granted the second 510(k) clearance surprised TearScience CEO Tim Willis, he says the sequential filings were […]
Medical device company TearScience has received 510(k) clearance on the latest version of its evaporative dry eye treatment. The Morrisville, North Carolina company’s novel dry eye treatment initially received U.S. Food and Drug Administration clearance last summer. The company’s LipiFlow device works by clearing the channels that supply the eye with the oily film that […]
Medical device company TearScience has secured $15 million in debt financing that the company will use to support a pair of products addressing evaporative dry eye. The venture debt financing comes from Oxford Finance and Silicon Valley Bank (NASDAQ:SIVB). To date, Morrisville, North Carolina-based TearScience has raised more than $70 million in venture capital financing […]
Medical device company TearScience has hired a former Allergan (NYSE:AGN) executive to spearhead European commercialization efforts for its novel dry eye treatment. Deithart Reichardt is now senior vice president of the European region for Morrisville, North Carolina-based dry eye treatment company TearScience. Reichardt will oversee sales, marketing, operations and customer service for the company in […]
A medical device dry-eye treatment that wants to replace eye drops has received U.S. Food and Drug Administration approval. North Carolina’s TearScience has won FDA approval for its LipiFlow Thermal Pulsation device, which can eliminate gland blockages that in many cases keep the eye from being properly lubricated. A limited number of the LipiFlow medical […]
